How severe is CVE-2006-5374?

CVE-2006-5374 has a CVSS 2.0 base score of 10.0, rated critical severity.

Is CVE-2006-5374 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 3% (87th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2006-5374?

CVE-2006-5374 affects Oracle Pharmaceutical. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2006-5374?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.

When was CVE-2006-5374 published?

CVE-2006-5374 was published on 2006-10-18 and last updated on 2026-06-16.

CVE-2006-5374

CVE-2006-5374 is a critical-severity vulnerability in Oracle Pharmaceutical with a CVSS 2.0 base score of 10.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: Critical (CVSS 2.0 base score 10.0)
EPSS exploit prediction: 3% (87th percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Oracle Pharmaceutical
Published: 2006-10-18
Last modified: 2026-06-16

Description

Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.

Frequently asked questions

What is CVE-2006-5374?: Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
How severe is CVE-2006-5374?: CVE-2006-5374 has a CVSS 2.0 base score of 10.0, rated critical severity.
Is CVE-2006-5374 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 3% (87th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2006-5374?: CVE-2006-5374 affects Oracle Pharmaceutical. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2006-5374?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2006-5374 published?: CVE-2006-5374 was published on 2006-10-18 and last updated on 2026-06-16.

References

Affected products (1)

cpe:2.3:a:oracle:pharmaceutical:4.5.1:*:*:*:*:*:*:*

More vulnerabilities in Oracle Pharmaceutical

CVE-2006-1884 — Critical (CVSS 10.0): Unspecified vulnerability in the Oracle Thesaurus Management System component in Oracle E-Business Suite and OPA 4.5.2…

All CVEs affecting Oracle Pharmaceutical →